Cargando…
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
FOXC2, a member of the forkhead box family of transcription factors, is an emerging oncogene that has been linked to several hallmarks of cancer progression. Among its many oncogenic functions is the promotion of drug resistance, with evidence supporting roles for FOXC2 in escape from broad classes...
Autores principales: | Hargadon, Kristian M., Strong, Elijah W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903043/ https://www.ncbi.nlm.nih.gov/pubmed/36740986 http://dx.doi.org/10.1177/15330338231155284 |
Ejemplares similares
-
The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
por: Zhang, Naibin, et al.
Publicado: (2023) -
Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Lian, Yunyu, et al.
Publicado: (2023) -
Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
por: Takeda, Yasutaka, et al.
Publicado: (2017) -
RNA-seq Analysis of Wild-Type vs. FOXC2-Deficient Melanoma Cells Reveals a Role for the FOXC2 Transcription Factor in the Regulation of Multiple Oncogenic Pathways
por: Hargadon, Kristian M., et al.
Publicado: (2020) -
Missplicing due to a synonymous, T96= exonic substitution in the T-box transcription factor TBX19 resulting in isolated ACTH deficiency
por: Maudhoo, Ashwini, et al.
Publicado: (2021)